Express Scripts' Three-Year Drug Trend Forecast Projects That Three of the Four Costliest Therapy Classes Will Be Specialty Conditions ST. LOUIS, May...
Study Shows Effects of Treatment with ABILIFY MAINTENA™ (Aripiprazole) on Psychiatric Hospitalization Rates for Patients with Schizophrenia...
Vortioxetine, a new multimodal agent in development for the treatment of major depression, shows effects on cognitive function in several preclinical...
Over the past two years, two studies showed the Niaspan cholesterol drug did not benefit patients. Yet AbbVie has managed to maintain revenue...
Another bright and cheery day here in the nation's medicine chest. We hope your return to work after the long weekend went well. Of course, there is much to do. Here are a few items to help you along...
Pfizer Paying Up To $725M For Alzheimer's Drug Rights (MarketWatch)
Zentiva Tells Shareholders To Reject Sanofi Bid (Yahoo/Reuters)
Merck Serono And ZymoGenetics Restructure Partnership (Xconomy.com)
